Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Pharmacokinetics Methodology: How GLP3Planner Models Drug Levels
referenceHow GLP3Planner's calculators model drug levels: a one-compartment model with first-order absorption and elimination (the Bateman function), plotted as milligrams in the body. Each parameter is listed with its source, the assumptions are marked, and the page explains the concentration estimate in the hourly table. Also covers the reconstitution math and the standard titration ladders.
Vendor Safety Methodology: How GLP3Planner Evaluates Peptide Sourcing
referenceEditorial methodology for vendor evaluation: 40 active US peptide research-chemical vendors assessed across six criteria, third-party verified against Finnrick Analytics and Janoshik Analytical, with the market reshuffle context that changed the trust calculus in 2025-2026.